Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors
Ronell Bologna‐Molina(Universidad de la República de Uruguay), G. Sanchez-Acuna(Hospital Oncológico Docente "Conrado Benítez García"), Adalberto Mosqueda‐Taylor(Universidad Autónoma Metropolitana), Nelly Molina‐Frechero(Universidad Autónoma Metropolitana), AD. Mori-Estevez(Hospital Oncológico Docente "Conrado Benítez García")
Cited by 253
Related Papers
Extranodal NK/T cell lymphoma, nasal type: An updated overview
|Critical Reviews in Oncology/Hematology|2021|111
Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas
|Oral Oncology|2008|83
Oral medicine (stomatology) across the globe: birth, growth, and future
|Oral Surgery Oral Medicine Oral Pathology and Oral Radiology|2015|66
Comparative expression of syndecan‐1 and Ki‐67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma
|Pathology International|2009|62
Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
|World Journal of Clinical Oncology|2019|58